L322-0473 Screening compound: N-[6-(butane-1-sulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-4-tert-butylbenzamide

L322-0473 Screening compound: N-[6-(butane-1-sulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-4-tert-butylbenzamide
L322-0473 Screening compound: N-[6-(butane-1-sulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-4-tert-butylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L322-0473
N-[6-(butane-1-sulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-4-tert-butylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L322-0473

Molecular Formula

C24H31N3O4S (C24 H31 N3 O4 S)

Compound Name

N-[6-(butane-1-sulfonyl)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-4-tert-butylbenzamide

IUPAC name

N-[6-(butane-1-sulfonyl)-13-dimethyl-2-oxo-23-dihydro-1H-13-benzodiazol-5-yl]-4-tert-butylbenzamide

SMILES

CCCCS(c(cc(c(N1C)c2)N(C)C1=O)c2NC(c1ccc(C(C)(C)C)cc1)=O)(=O)=O

InChI

InChI=1S/C24H31N3O4S/c1-7-8-13-32(30,31)21-15-20-19(26(5)23(29)27(20)6)14-18(21)25-22(28)16-9-11-17(12-10-16)24(2,3)4/h9-12,14-15H,7-8,13H2,1-6H3,(H,25,28)

InChI Key

IULCHFMZWONXOM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27245021

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

457.59

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.303

Distribution Coefficient, logD

5.277

Water Solubility, LogSw

-5.18

Polar Surface Area

69.353

Acid Dissociation Constant (pKa)

8.61

Base Dissociation Constant (pKb)

-2.73

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.70

L322-0473 in Drug Discovery

Included in Screening Libraries

Hsp90-Targeted Library (11355 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system

References: we are preparing a list of scientific research reports with L322-0473 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L322-0473?
Check Price and Availability of L322-0473, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L322-0473 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L322-0473
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L322-0473
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L322-0473 available by request